LITS
Lite Strategy, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$25.17M
P/E Ratio
—
EPS
$-2.08
Beta
0.04
52W High
$8.25
52W Low
$0.69
50-Day MA
$1.08
200-Day MA
$1.67
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
4.62
PEG Ratio
2.22
About Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-1.97M |
| EBITDA | $-17.13M |
| Operating Margin | 0.00% |
| Return on Equity | -159.30% |
| Return on Assets | -27.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.62 |
| Price-to-Book | 0.45 |
| Price-to-Sales (TTM) | 0.31 |
| EV/Revenue | 0.812 |
| EV/EBITDA | 2.38 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $34.03M |
| Float | $26.43M |
| % Insiders | 11.96% |
| % Institutions | 17.32% |
Historical Volatility
HV 10-Day
110.80%
HV 20-Day
83.22%
HV 30-Day
78.90%
HV 60-Day
66.88%
HV Rank
38.5%
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 6/13/2026